Emergent BioSolutions Receives Saudi Food and Drug Authority Approval for ACAM2000® [Smallpox and Mpox (Vaccinia) Vaccine, Live]
Emergent BioSolutions announced that the Saudi Food and Drug Authority (SFDA) has approved ACAM2000 for the prevention of smallpox and mpox in high-risk individuals. This marks the first Emergent product licensed by the SFDA, signaling expanded government adoption in the Gulf region.
Key figures
- Drug Name
- ACAM2000
- Global mpox cases
- 137,000
- Global mpox deaths
- 300
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.